Exos Asset Management’s NeoGenomics NEO Stock Holding History

Exos Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-604	Closed	-$27K	–	611
2021 Q2	$27K	Buy	+604	New	+$26.8K	0.01%	657

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Exos Asset Management's NEO Position: Q3 2021 in Review

Exos Asset Management sold out of NeoGenomics (NEO) in Q3 2021, closing a stake of 604 shares — an estimated $27K sold.

Exos Asset Management first reported a position in NEO in Q2 2021 and held it in 1 quarter. The position peaked at $27K in Q2 2021. 324 funds tracked by Wall St. Rank hold NEO as of Q3 2021.

Exos Asset Management reported no remaining NeoGenomics position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 604 NeoGenomics shares in Q3 2021, an estimated $27K.
Exos Asset Management first reported a position in NeoGenomics in Q2 2021 and held it in 1 quarter.
Exos Asset Management's NeoGenomics position peaked at $27K in Q2 2021.
324 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.